The correlation between CYP1A2 overexpression and better event-free survival, probably is due to doxorubicin toxicity mediated by CYP1A2 enzyme against OS cancer cells, since CYP1A2 metabolizes this chemotherapy drug [40]. The gene discussed is CYP1A2; the disease is cancer.